Blockchain Registration Transaction Record
BioMed X and Ono Pharmaceutical Co., Ltd. Collaborate on New Immunotherapy Research Team
BioMed X and Ono Pharmaceutical Co., Ltd. have partnered to establish a new research team focusing on next-generation immunotherapies, aiming to investigate the antitumor effects of neutrophils. The collaboration may lead to groundbreaking treatments for cancer patients, impacting the future of cancer treatment.
This news matters as it highlights the collaboration between BioMed X and Ono Pharmaceutical to conduct groundbreaking research on next-generation immunotherapies, offering potential breakthroughs in cancer treatment. The partnership may lead to the development of more effective therapies for cancer patients, impacting the future of cancer treatment.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x7d14628bd711616e26ae0425ca4ccfbc42aaf0f3f432f68bfa7b937f17a651ed |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | warpkK6n-8b0ce706d098a59d9f02146296866f95 |